Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 213 Myelodysplastic Syndromes 82 Leukemia 44 Leukemia, Myelomonocytic, Chronic 35 Recurrence 16 Myeloproliferative Disorders 15 Neoplasm, Residual 10 Lymphoma, T-Cell, Peripheral 10 Leukemia, Biphenotypic, Acute 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Lymphoma 8 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7 Myelodysplastic-Myeloproliferative Diseases 7 Lymphoma, Large B-Cell, Diffuse 7 Anemia, Refractory, with Excess of Blasts 7 Primary Myelofibrosis 6 Lymphoma, Non-Hodgkin 6 Hodgkin Disease 6 Congenital Abnormalities 6 Lymphoma, T-Cell 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Leukemia, Monocytic, Acute 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Hematologic Neoplasms 5 Polycythemia Vera 4 Pancreatic Neoplasms 4 Multiple Myeloma 4 Lymphoma, Follicular 4 Lymphoma, Extranodal NK-T-Cell 4 Leukemia, Myeloid 4

Interventions

Sunitinib 26 Everolimus 20 Bevacizumab 19 aldesleukin 18 Sorafenib 16 Nivolumab 16 Interleukin-2 14 pembrolizumab 13 Peripheral Blood Stem Cell Transplantation 13 fludarabine phosphate 12 Radiotherapy 12 Interferon-alpha 12 Cyclophosphamide 12 Radiosurgery 11 Filgrastim 11 Blood Specimen Collection 11 Ipilimumab 10 Gemcitabine 10 Axitinib 9 Surveys and Questionnaires 7 Gene Expression Profiling 7 Cryosurgery 7 temsirolimus 6 pazopanib 6 Surgical Procedures, Operative 6 durvalumab 5 cabozantinib 5 atezolizumab 5 Mycophenolic Acid 5 Immunohistochemistry 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Kidney Neoplasms × Azacitidine × Clear all

NCT00934440 2017-06-14

5-AZ

University of Kansas Medical Center

Phase 1/2 Terminated

11 enrolled 10 charts

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡